Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Donor Specific Antibody (DSA) Monitoring Protocol To Detect Patient Characteristics and /or Changes In Immunosuppression on the Development of De Novo Antibodies

NCT01382355 is registered in ClinicalTrials.gov with Providence Health & Services as lead sponsor.

NCT NCT01382355
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01382355 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Donor Specific Antibody (DSA) Monitoring Protocol To Detect Patient Characteristics and /or Changes In Immunosuppression on the Development of De Novo Antibodies
Lead sponsor
Providence Health & Services
Phase
Observational
Overall status
Unknown status
Start date
August 31, 2011
Completion date
August 31, 2012
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplant, kidney/pancreas transplant